- Home
- LSTA vs FGF Comparison
LSTA vs FGF Comparison
Compare LSTA & FGF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- FGF
- Stock Information
- Founded
- LSTA 1980
- FGF 2012
- Country
- LSTA United States
- FGF United States
- Employees
- LSTA N/A
- FGF N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- FGF Property-Casualty Insurers
- Sector
- LSTA Health Care
- FGF Finance
- Exchange
- LSTA Nasdaq
- FGF Nasdaq
- Market Cap
- LSTA 31.2M
- FGF 28.0M
- IPO Year
- LSTA N/A
- FGF N/A
- Fundamental
- Price
- LSTA $3.71
- FGF $22.58
- Analyst Decision
- LSTA Strong Buy
- FGF
- Analyst Count
- LSTA 1
- FGF 0
- Target Price
- LSTA $15.00
- FGF N/A
- AVG Volume (30 Days)
- LSTA 53.5K
- FGF 58.2K
- Earning Date
- LSTA 02-27-2025
- FGF 03-13-2025
- Dividend Yield
- LSTA N/A
- FGF N/A
- EPS Growth
- LSTA N/A
- FGF N/A
- EPS
- LSTA N/A
- FGF N/A
- Revenue
- LSTA N/A
- FGF $22,351,000.00
- Revenue This Year
- LSTA N/A
- FGF N/A
- Revenue Next Year
- LSTA N/A
- FGF N/A
- P/E Ratio
- LSTA N/A
- FGF N/A
- Revenue Growth
- LSTA N/A
- FGF N/A
- 52 Week Low
- LSTA $2.19
- FGF $14.21
- 52 Week High
- LSTA $4.20
- FGF $38.50
- Technical
- Relative Strength Index (RSI)
- LSTA 66.07
- FGF 50.25
- Support Level
- LSTA $3.52
- FGF $18.81
- Resistance Level
- LSTA $3.87
- FGF $22.33
- Average True Range (ATR)
- LSTA 0.29
- FGF 2.56
- MACD
- LSTA 0.02
- FGF 0.20
- Stochastic Oscillator
- LSTA 63.97
- FGF 46.87
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.
About FGF FG Financial Group Inc. (NV)
Fundamental Global Inc through its subsidiaries operates as diversified insurance, reinsurance, and investment management holding company. The company's segment includes Insurance and Asset Management. It generates maximum revenue from the Insurance segment.